AIDS news from FiercePharma
News
Merck cuts deals on AIDS meds
Merck is garnering some goodwill in the AIDS community with price-freezes and discounts on its HIV-fighting drugs. First, Merck agreed to keep the new, Read more...
HIV drugs may find preventive use
Should HIV drugs be used to prevent infection with the deadly virus? Some say yes. Given the fact that vaccine developers have to Read more...
Lancet: Glaxo HIV med boosts cardiac risk
A leading AIDS med made by GlaxoSmithKline carries nearly double the risk of heart attack compared with other anti-HIV meds, according to a new study published by the Lancet. Abacavir--which Read more...
Get more AIDS coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets